TLX · Healthcare · $3.7B
$10.80-1.59%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
3/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“매출이 477백만 달러로 전년 동기 대비 22% 늘었고, 최근 추이도 414백만 달러에서 가속됐어요.”
In the company's words · 2026 2분기 earnings call